Quantcast

Latest neurodegenerative diseases Stories

2014-09-18 08:29:48

- Dr. Altstiel brings over 30 years of expertise in neurodegenerative diseases - NEWARK, N.J., Sept. 18, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment of Larry D. Altstiel, M.D., Ph.D. to the Company's Board of Directors, effective September 12, 2014. The appointment of Dr. Altstiel fills a vacancy on the Board of seven members. Dr. Altstiel will also become Chairman of the Nominating and Corporate Governance Committee and a member of the Audit...

2014-06-26 16:23:38

Paper Addresses Challenges and Explores Opportunities to Stimulate Repurposing of FDA-Approved Drugs for Alzheimer's, Parkinson's and Related Diseases NEW YORK, June 26, 2014 /PRNewswire-USNewswire/ -- A new peer-reviewed publication from the Alzheimer's Drug Discovery Foundation (ADDF) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) offers strategic insight on how philanthropy, industry and government organizations can advance repurposing of U.S. Food and Drug...

2014-06-09 10:30:56

University at Buffalo New study finds that blockages in fruit fly brains quickly form and dissolve; it could help treat Alzheimer’s and Huntington’s diseases Motorists in Los Angeles, San Francisco and other gridlocked cities could learn something from the fruit fly. Scientists have found that cellular blockages, the molecular equivalent to traffic jams, in nerve cells of the insect’s brain can form and dissolve in 30 seconds or less. The findings, presented in the journal...

2014-04-28 23:13:23

Forum Uniquely Brings Together Leading Family Offices and Their Foundations Seeking Impact Investment, Grant-Giving, and Philanthropy Opportunities within Health and Life Sciences New York, NY (PRWEB) April 28, 2014 FPRT Bio, a clinical stage company developing a novel anti-inflammatory drug therapy for the treatment for neurodegenerative diseases including ALS, Parkinson’s and Alzheimer’s disease, announced today it has been selected to present at the Cavendish Global Health Impact...

2014-04-24 10:52:56

TAU discovers that protein clusters implicated in neurodegenerative diseases actually serve to protect brain cells People diagnosed with Huntington's disease, most in their mid-thirties and forties, face a devastating prognosis: complete mental, physical, and behavioral decline within two decades. "Mutant" protein clusters, long blamed for the progression of the genetic disease, have been the primary focus of therapies in development by pharmaceutical companies. But according to new...

2014-04-22 12:09:23

Research published in the Journal of Molecular Biology Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a characteristic common to many toxic, misfolded proteins, not just...

2014-04-22 08:30:14

--Research Published in the Journal of Molecular Biology-- CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases. These molecules are based on what the Company calls a general amyloid interaction motif, or GAIM, which recognizes a...

2014-03-25 08:31:05

--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the Company's lead candidate, NPT088, and potential next-generation compounds toward clinical trials. NPT088 has the potential to treat a wide range of neurodegenerative diseases,...

2014-01-31 12:25:20

U.S. Sen. Charles E. Schumer Helps Commemorate Opening of Building that Nearly Doubles Medical College's Research Space, Enhances Student Education NEW YORK, Jan. 31, 2014 /PRNewswire/ -- Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill...

Pesticide Banned In The USA Linked To Alzheimer's Disease
2014-01-29 07:46:56

Rebekah Eliason for redOrbit.com – Your Universe Online For over 40 years scientists have recognized that DDT, a synthetic pesticide, harms bird habitats and is a threat to the environment. Although DDT was banned in the United States in 1972, other countries continue to use it as a pesticide. According to a new study from Rutgers University, exposure to DDT may cause increased risk and severity of Alzheimer’s disease. This is particularly true for people over 60 years of age. As...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related